| Keywords: |
clinical trial; review; nonhuman; human immunodeficiency virus infection; organization and management; drug screening; drug evaluation, preclinical; drug design; biotechnology; standard; financial management; economics; immunology; multicenter study; immunogenicity; vaccination; clinical research; organization; human immunodeficiency virus; acquired immune deficiency syndrome; virus infection; health; clinical laboratory; public policy; clinical trials; hiv infections; policy; human immunodeficiency virus 1; international cooperation; patent; hiv-1; world health; drug industry; drug manufacture; intellectual property; multicenter studies; human immunodeficiency virus vaccine; private sector; aids vaccines; academies and institutes; good manufacturing practice; research support; public sector; humans; human; priority journal; article; financial support
|
